Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 3:01 pm Sale | 13G | Sierra Oncology Inc. SRRA | Rock Springs Capital Management LP | 0 0.000% | -1,184,793 (Position Closed) | View |
| 2023-02-10 4:20 pm Sale | 13G | Sierra Oncology Inc. SRRA | Versor Investments LP | 0 0.000% | -1,266,927 (Position Closed) | View |
| 2022-07-11 4:30 pm Sale | 13D | Sierra Oncology Inc. SRRA | Abingworth LLP | 0 0.000% | -2,193,626 (Position Closed) | View |
| 2022-07-05 5:06 pm Sale | 13G | Sierra Oncology Inc. SRRA | Vivo Capital IX LLC | 0 0.000% | -2,735,852 (Position Closed) | View |
| 2022-05-06 4:33 pm Sale | 13D | Sierra Oncology Inc. SRRA | Longitude Capital Partners III LLC | 1,485,140 5.700% | -2,140,130 (-59.03%) | View |
| 2022-04-22 2:32 pm Purchase | 13G | Sierra Oncology Inc. SRRA | Versor Investments LP | 1,266,927 5.300% | 1,266,927 (New Position) | View |
| 2022-03-29 4:23 pm Purchase | 13G | Sierra Oncology Inc. SRRA | Frazier Life Sciences Public Fund L.P. | 2,366,853 10.000% | 1,562,186 (+194.14%) | View |
| 2022-03-21 4:52 pm Unchanged | 13D | Sierra Oncology Inc. SRRA | Abingworth LLP | 2,193,626 8.900% | 0 (Unchanged) | View |
| 2022-03-15 4:30 pm Unchanged | 13D | Sierra Oncology Inc. SRRA | ORBIMED ADVISORS LLC | 3,044,753 12.200% | 0 (Unchanged) | View |
| 2022-02-14 6:25 pm Purchase | 13G | Sierra Oncology Inc. SRRA | Rock Springs Capital Management LP | 1,184,793 7.870% | 617,435 (+108.83%) | View |
| 2022-02-14 4:21 pm Sale | 13G | Sierra Oncology Inc. SRRA | Venrock Healthcare Capital Partners II L.P. | 984,746 6.100% | -7,304,732 (-88.12%) | View |
| 2022-02-14 3:57 pm Sale | 13G | Sierra Oncology Inc. SRRA | CAXTON CORP | 1,119,322 7.000% | -23,039 (-2.02%) | View |
| 2022-02-11 5:22 pm Purchase | 13G | Sierra Oncology Inc. SRRA | Vivo Capital IX LLC | 2,735,852 14.700% | 799,999 (+41.33%) | View |
| 2022-02-11 4:57 pm Unchanged | 13G | Sierra Oncology Inc. SRRA | New Leaf Biopharma Opportunities I L.P. | 787,414 4.100% | 0 (Unchanged) | View |
| 2022-02-10 5:00 pm Purchase | 13D | Sierra Oncology Inc. SRRA | Abingworth LLP | 2,193,626 11.300% | 150,000 (+7.34%) | View |
| 2022-02-10 4:55 pm Purchase | 13G | Sierra Oncology Inc. SRRA | GILEAD SCIENCES INC. GILD | 1,450,566 9.200% | 377,266 (+35.15%) | View |
| 2022-02-10 10:54 am Purchase | 13G | Sierra Oncology Inc. SRRA | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,230,468 8.170% | 436,328 (+54.94%) | View |
| 2022-02-07 5:12 pm Purchase | 13G | Sierra Oncology Inc. SRRA | PFM Health Sciences LP | 1,062,888 5.500% | 1,062,888 (New Position) | View |
| 2022-02-04 5:22 pm Purchase | 13D | Sierra Oncology Inc. SRRA | Longitude Capital Partners III LLC | 3,625,270 17.400% | 175,000 (+5.07%) | View |
| 2022-02-02 4:33 pm Unchanged | 13D | Sierra Oncology Inc. SRRA | ORBIMED ADVISORS LLC | 3,044,753 15.300% | 0 (Unchanged) | View |